Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
EnGen Bio
company
About
EnGen Bio is a development-stage biotechnology company that pioneers a new approach to preventing and treating influenza.
- 11 - 50
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $180K
- Industries
- Biotechnology,Health Care,Health Diagnostics,Life Science
- Founded date
- Jan 1, 2016
- Number Of Employee
- 11 - 50
- Operating Status
- Active
EnGen Bio is a development-stage biotechnology company that pioneers a new approach to preventing and treating influenza. It believes that it has identified a candidate Universal Type A Influenza vaccine. Influenza drugs and vaccines are unique because there is sufficient government funding available to develop these assets well into human clinical trials, and possibly to market. EnGen Bio is aggressively pursuing this and similar opportunities.It is founded in 2017 and is headquartered in Redwood City, California.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$180K
EnGen Bio has raised a total of
$180K
in funding over 2 rounds. Their latest funding was raised on
Nov 27, 2012 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 27, 2012 | Grant | $180K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
EnGen Bio is funded by 1 investors.
National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
